Relationship Between 1,5-Anhydroglucitol and Renal Function Assessed by Dynamic Renal Scintigraphy in Type 2 Diabetes

Abstract Context The reliability of serum 1,5-anhydroglucitol (1,5-AG) in patients with type 2 diabetes and renal insufficiency remains controversial. Objective To evaluate the relationship between renal function and serum 1,5-AG and to assess the extent to which renal function influences 1,5-AG. Methods A total of 5337 participants with type 2 diabetes were enrolled. The measured glomerular filtration rate (mGFR) was assayed using 99mTc-DTPA dynamic renal scintigraphy. All subjects were stratified into 5 groups based on mGFR (≥120 n = 507, 90-120 n = 2015, 60-90 n = 2178, 30-60 n = 604, and 30 mL/min/1.73 m2 n = 33). Results Overall, the serum 1,5-AG and mGFR levels were 3.3 (1.7-7.0) μg/mL and 88.6 ± 24.1 mL/min/1.73 m2, respectively. mGFR was found to be negatively correlated with 1,5-AG levels (r = −0.189, P .001). Multiple linear regression revealed that mGFR was independently and negatively related to serum 1,5-AG after adjusting for covariates including hemoglobin A1c (HbA1c; P .001). In subgroups with mGFR ≥ 30 mL/min/1.73 m2, the correlation coefficients between 1,5-AG and HbA1c, fasting plasma glucose, postprandial plasma glucose, and the differences between postprandial and fasting plasma glucose remained significant (range, −0.126 to −0.743, all P .01). However, the link between 1,5-AG and traditional glycemic markers was attenuated in individuals with mGFR 30 mL/min/1.73 m2. Sensitivity analysis after excluding anemic patients showed similar results regarding the relationship between serum 1,5-AG and HbA1c across the mGFR subgroups. Conclusion Although we observed a weak inverse correlation (r = −0.189) between mGFR and serum 1,5-AG in type 2 diabetes, 1,5-AG remains a valid marker for assessing glucose control in subjects with mild or moderate renal dysfunction.